Nantahala reports 5.78M shares (9.99%) in Abeona
ABEONA THERAPEUTICS INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ABEONA THERAPEUTICS INC. Schedule 13G/A amendment reports that Nantahala Capital Management, LLC and its managing members, Wilmot B. Harkey and Daniel Mack, may be deemed beneficial owners of 5,775,350 shares of common stock as of March 31, 2026. The filing states these holdings represent 9.99% of the outstanding shares for each Reporting Person. The disclosure notes 762,298 shares of the total may be acquired within sixty days through the exercise of convertible securities. Shared voting and dispositive power over the 5,775,350 shares is recorded for Nantahala, Harkey and Mack.
Insights
Large passive stake disclosed: 5,775,350 shares (9.99%) held through Nantahala.
The filing shows Nantahala and two managing members each report beneficial ownership of 5,775,350 shares, equal to 9.99% as of March 31, 2026. This stake is reported under shared voting and dispositive power, indicating control via managed funds and accounts.
Watch subsequent public filings for any changes in percent ownership or disclosures if convertible securities are exercised within sixty days; timing and cash-flow treatment are not provided in the excerpt.
Schedule 13G/A amendment correctly attributes shared dispositive power and exerciseable conversion exposure.
The amendment states the 5,775,350 shares include 762,298 shares exercisable within sixty days through convertible securities, and identifies Nantahala as an adviser with controlled funds. Each Reporting Person is listed as a control person in respect of these holdings.
Key compliance items: the filing cites beneficial ownership percentages and identifies the fund with dividend/receipt rights. Further amendments may follow if conversions occur or ownership thresholds change.
Key Figures
Key Terms
beneficial owner regulatory
Schedule 13G/A regulatory
convertible securities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Nantahala report in ABEONA (ABEO)?
What voting and disposition powers are reported for ABEO holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.